
You can purchase shares of Eikon Therapeutics (NASDAQ:EIKN) through any online brokerage.
Other companies in Eikon Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Eikon Therapeutics has a consensus price target of $24.67.
The stock price for Eikon Therapeutics (NASDAQ: EIKN) is $6.67 last updated November 12, 2026 at 9:30 AM EST.
There are no upcoming dividends for Eikon Therapeutics.
Eikon Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Eikon Therapeutics.
Eikon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating...